Cisplatin Chemotherapy Drug: Uses, Side Effects and Precautions
Written by Medicover Team and Medically Reviewed by Dr Jeepalem Sai Moulika, Oncology
Cisplatin is a platinum-based chemotherapy medication that has been a cornerstone of cancer treatment since 1978. This powerful anticancer drug is commonly used to treat various solid tumors including testicular, ovarian, bladder, head and neck, lung, and cervical cancers.
Cisplatin has demonstrated remarkable effectiveness, particularly in testicular cancer where it has significantly improved survival rates and cure rates.
Cisplatin is a coordination complex of platinum with the chemical formula cis-[Pt(NH3)2Cl2]. It belongs to a class of chemotherapy drugs called alkylating agents and contains the metal platinum, which gives it its unique anticancer properties.
The drug is administered exclusively through intravenous injection as a sterile solution and requires careful monitoring during treatment.
Cisplatin Injection offers significant therapeutic benefits for cancer patients, particularly when used in combination with other chemotherapy drugs.
The drug has shown remarkable efficacy in treating multiple cancer types and has become an essential component of many treatment protocols.
Cisplatin is FDA-approved to treat several types of cancer:
Beyond its primary indications, cisplatin is also used to treat:
Cisplatin's mechanism of action involves a complex process that ultimately leads to cancer cell death. The drug works by interfering with DNA replication and repair mechanisms.
Once administered intravenously, cisplatin remains stable in the bloodstream due to high chloride concentrations. Upon entering cancer cells, the drug undergoes aquation, where water molecules slowly replace chloride ions. This process creates an electrophilic compound that has a strong affinity for DNA.
The activated cisplatin then binds to the N7 reactive centers on purine bases, particularly guanine residues in DNA. This binding creates DNA cross-links between adjacent guanine molecules, which prevents DNA replication and transcription.
The DNA damage triggers cellular repair mechanisms, but when repair fails, the cell undergoes programmed cell death (apoptosis).
Cisplatin dosage must be carefully calculated based on the patient's clinical condition, body surface area, renal function, and response to treatment. The drug requires precise administration to maximize therapeutic benefits while minimizing toxicity.
Standard Adult Dosing Regimens:
Pediatric use: Dosing regimens differ and should be referenced from specific protocols; cisplatin is not always recommended for children outside specialized settings.
Maximum dose per cycle is generally 100 mg/m².
Always refer to the specific treatment protocol and consult with oncology specialists for individualized dosing and modifications.
If you miss a scheduled cisplatin dose, contact your doctor or pharmacist immediately for a new dosing schedule. Never attempt to double doses or self-adjust the timing, as cisplatin requires precise scheduling to maintain effectiveness and safety.
Cisplatin overdose is a serious medical emergency that requires immediate attention. Healthcare providers exercise extreme caution to prevent inadvertent overdosage, with special warnings for doses exceeding 100 mg/m²per cycle.
Overdose symptoms may include severe kidney damage, hearing loss, severe nausea and vomiting, and dangerous drops in blood cell counts. Seek emergency medical attention immediately if overdose is suspected.
Avoid aluminum-containing equipment during preparation and administration, as aluminum reacts with cisplatin causing precipitation and loss of potency.
Get a second opinion from trusted experts and makeconfident, informed decisions.
Get Second OpinionCisplatin is associated with significant side effects that require careful monitoring and management. While effective against cancer, the drug can cause both common and serious adverse reactions that patients and healthcare providers must be prepared to address.
The most frequently reported cisplatin side effects include:
More serious adverse reactions that require immediate medical attention include:
Patients should consult their doctor immediately if any symptoms worsen or if they experience signs of serious side effects such as unusual bleeding, vision changes, hearing problems, or symptoms of infection.
Cisplatin carries several black box warnings due to its potential for serious toxicity. Healthcare providers must carefully evaluate patients before treatment and monitor closely throughout therapy.
Patients with the following conditions should not receive cisplatin:
Special monitoring is required for patients with:
While cisplatin can be used in pediatric patients, special considerations apply. Children may be more susceptible to hearing loss and kidney damage. Elderly patients also require careful monitoring due to age-related decline in kidney function.
Patients should avoid alcohol during cisplatin treatment as it may increase the risk of kidney damage and interfere with the body's ability to fight infection. Adequate hydration is essential; patients should increase their fluid intake as directed by their healthcare team.
Cisplatin can interact with numerous medications, potentially increasing toxicity or reducing effectiveness. Healthcare providers must carefully review all medications before starting treatment.
Nephrotoxic drugs pose the highest risk when combined with cisplatin. These include aminoglycoside antibiotics, amphotericin B, and certain diuretics, which can increase kidney damage risk.
Ototoxic medications such as loop diuretics and aminoglycosides can increase the risk of hearing loss when used with cisplatin.
Phenytoin levels may be affected by cisplatin, requiring dose adjustments and monitoring of anticonvulsant therapy.
Patients should inform their healthcare team about all supplements and herbal products, as some may interfere with cisplatin's effectiveness or increase side effects. Antioxidant supplements may theoretically reduce cisplatin's anticancer activity, though clinical evidence is limited.
Proper storage of cisplatin is critical for maintaining drug stability and preventing degradation. Healthcare facilities must follow strict storage protocols to ensure patient safety and drug efficacy.
Cisplatin injection should be stored at controlled room temperature between 15°C to 25°C (59°F to 77°F). The drug must not be refrigerated, as cold temperatures can cause precipitation and loss of potency.
Improper storage can lead to drug precipitation, loss of potency, and potential safety hazards. Refrigeration or freezing will cause the active ingredient to precipitate out of solution, making the drug ineffective.
The drug should be protected from light and kept in its original container until use. Any unused portions must be discarded properly according to hazardous drug disposal protocols, and the medication must be kept away from children and pets at all times.
| Cisplatin | Carboplatin |
|---|---|
| Cisplatin is the generic name; it is sold under the trade name Platinol. | Carboplatin is sold under the trade name Paraplatin. |
| Formula: [Pt(NH3)2Cl2] | C6H12N2O4Pt |
| Molar mass: 301.1 g/mol | Molar mass: 371.249 g/mol |
| A chemotherapy medication used for cancer treatment. | A chemotherapy medication used for cancer treatment. |
| Cisplatin is used to treat head and neck cancer, testicular cancer, ovarian cancer, cervical cancer, breast cancer, bladder cancer, esophageal cancer, lung cancer, mesothelioma, and brain tumors. | Carboplatin is used to treat a number of forms of cancer, often as an alternative to cisplatin due to its reduced toxicity profile. |
| Administered by injection into a vein. | Administered by injection into a vein. |

Still have questions? Speak with our experts now!
040-68334455Platinum-based chemotherapy drugs are among the most potent and widely used anticancer drugs. They have toxic side effects, however, and tumors can become resistant to them. Cisplatin is the most common platinum chemotherapy drug.
Cisplatin is one of the most effective anti-cancer agents widely used in the treatment of solid tumors. It is generally considered to be a cytotoxic drug that kills cancer cells by damaging DNA and inhibiting DNA synthesis.
Cisplatin or cis-diamminedichloroplatinum (II) is a well-known chemotherapy drug. It has been used to treat a number of human cancers including bladder, head and neck, lung, ovarian, and testicular cancers.
Nausea and vomiting usually begin within 1 to 4 hours of treatment and last up to 24 hours. Various levels of vomiting, nausea, and/or anorexia may persist for up to 1 week after treatment.
Cisplatin is a potent and valuable chemotherapy agent used to treat a wide range of malignancies. Renal tubular dysfunction and cumulative impairment of renal function, as evidenced by a decrease in the glomerular filtration rate (GFR), may be dose-limiting.
Cisplatin is unique in that it can cause late cardiovascular complications such as hypertension, left ventricular hypertrophy, myocardial ischemia, and myocardial infarction (MI) for up to 10 to 20 years after remission of metastatic testicular cancer.
Cisplatin injection is commonly used as a chemotherapy medication to treat various types of cancer. It is particularly effective in managing testicular, ovarian, bladder, and lung cancers, and is often administered in combination with other cancer-fighting drugs. By interfering with the DNA in cancer cells, cisplatin prevents them from multiplying and helps shrink tumors. Its strong antitumor activity has made it a cornerstone in many chemotherapy protocols.
Cisplatin 50 mg refers to a specific dosage strength of the drug and is typically used during chemotherapy cycles for cancers like testicular cancer, ovarian cancer, cervical cancer, and non-small cell lung cancer. The 50 mg dose is usually diluted and administered intravenously under strict medical supervision, based on the patient’s body surface area, type of cancer, and overall treatment plan. The exact dosage and frequency depend on individual patient factors and the cancer being treated.
Cisplatin and carboplatin are not exactly the same, but they belong to the same class of chemotherapy drugs known as platinum-based compounds. While both are used to treat similar types of cancers, such as ovarian and lung cancer, they differ in their chemical structure, toxicity profile, and side effects. Cisplatin is generally more potent but has a higher risk of causing kidney damage, nausea, and vomiting. Carboplatin, on the other hand, tends to have fewer kidney-related side effects and is often used as an alternative when patients cannot tolerate cisplatin.
Yes, cisplatin chemotherapy can lead to hair loss in some patients, although the severity varies. Hair loss occurs because the drug targets rapidly dividing cells, and hair follicles fall into that category. However, not everyone experiences significant hair loss, and it often depends on the dose, treatment duration, and whether cisplatin is combined with other chemotherapy agents. In most cases, hair usually grows back after the treatment ends.
Disclaimer: The information provided is accurate and up-to-date to the best of our knowledge. However, it should not be considered a substitute for medical advice or consultation. We do not guarantee its completeness or accuracy. The absence of specific warnings does not mean a medicine is safe for all users. We are not responsible for any outcomes based on this information and strongly recommend consulting a doctor for any medical concerns or questions.